European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk
A joint consensus statement from the European Society of Cardiology and the European Atherosclerosis Society Task Force.
Publication in full
- European Heart Journal DOI: http://dx.doi.org/10.1093/eurheartj/ehw480
First published online: 27 October 2016 - Download full text PDF
Authors
Ulf Landmesser, M. John Chapman, Michel Farnier, Baris Gencer, Stephan Gielen, G. Kees Hovingh, Thomas F. Lüscher, David Sinning, Lale Tokgözoglu, Olov Wiklund, Jose Luis Zamorano, Fausto J. Pinto, and Alberico L. Catapano on behalf of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Editorial
To be announced
